COVID-19 Vaccine Updates and Information
The Australian Technical Advisory Group on Immunisation (ATAGI) has updated its recommendations for a winter dose of COVID-19 vaccine to help reduce severe disease from the emerging surge of Omicron BA.4 and BA.5 subvariant infections, and to reduce the burden on Australian hospitals and the healthcare system in coming months.
How many vaccine doses do you need?
Some people with severe or complex health needs may need additional doses.
ATAGI has also recommended the interval for the fourth dose be reduced to 3 months after your initial booster.
If you’ve had COVID-19, you should get your next dose 3 months after you’ve recovered.
Read more here.
Talk to your local Aboriginal Community Controlled Health Organisation (ACCHO) or book your appointment here.
The Pharmaceutical Benefits Advisory Committee has expanded the eligibility criteria for COVID-19 oral antiviral treatments, Paxlovid (nirmatrelvir and ritonavir) and molnupiravir (Lagevrio) effective from 11 July 2022.
New eligibility includes updated age limits and risk factors.
They are now available for Aboriginal or Torres Strait Islander, 30 years or older and with 2 risk factors.
Risk factors include:
People aged 18 years and older who are moderately to severely immunocompromised and test positive for COVID-19.
It is important people continue to get tested early if they have symptoms as these drugs need to be given in the first 5 days of the illness.
Additional information can be found in the following factsheets:
For more information, please see: https://www.health.gov.au/oral-treatments